GLP-1 therapy is not just about taking an injection
To view a copy of this licence, visit About this article Cite this article Gomez, D.R., Swartzman, I., Linderholm, A
The significant prevalence of AITD, a long latent period and the involvement of autoimmune processes in their occurrence, development of concomitant diseases, insufficient effectiveness of the main pharmacotherapy, and a decrease in the quality of life of patients require the development of adequate approaches for the correction of immune processes in order to prevent and treat diseases
See our prior blogs.
For male patients, limited data suggest potential improvements in testosterone levels in men with obesity and hypogonadism, likely secondary to weight loss and reduced aromatase activity in adipose tissue
Muscles burn more calories at rest than fat does, so promoting lean muscle through peptides can lead to higher metabolism in the long run